Determination of oligonucleotides for therapeutics, diagnostics and research reagents
US6022691A · kind A · utility
9Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 1997 |
| Grant date | Feb 8, 2000 |
| Priority date | — |
| Expiry date | Nov 7, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/6811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Oligonucleotides which selectively bind to target biomolecules are determined by in vitro assay of a pool of random oligonucleotides for activity against the biomolecules, followed by recovery and characterization of selected oligonucleotides. Oligonucleotides so determined may be utilized for therapeutic, diagnostic and research reagent purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.